Draft Guidance On Lab-Produced Tests Being Misinterpreted – Gutman
This article was originally published in The Gray Sheet
Executive Summary
Stakeholders have developed "misconceptions" regarding a recent draft guidance published by FDA on certain laboratory-developed assays, says Steve Gutman, director of the CDRH Office of In Vitro Diagnostic Device Evaluation & Safety